Search Results - "Żuber, Zbigniew"

Refine Results
  1. 1
  2. 2

    Comment on the article "Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for Rheumatology" by Żuber, Zbigniew

    Published in Reumatologia (2018)
    “…Extensive team work is in my opinion an excellent presentation of current knowledge about the new drug, actually a new group of small-molecule targeted DMARDs…”
    Get full text
    Journal Article
  3. 3

    Diagnostic Value of Whole-Body MRI in Pediatric Patients with Suspected Rheumatic Diseases by Ożga, Joanna, Ostrogórska, Monika, Wojciechowski, Wadim, Żuber, Zbigniew

    Published in Medicina (Kaunas, Lithuania) (28-08-2024)
    “…: The diagnosis of rheumatic diseases in children is challenging and requires the use of advanced imaging examinations such as whole-body magnetic resonance…”
    Get full text
    Journal Article
  4. 4

    Role of Microparticles in the Pathogenesis of Inflammatory Joint Diseases by Krajewska-Włodarczyk, Magdalena, Owczarczyk-Saczonek, Agnieszka, Żuber, Zbigniew, Wojtkiewicz, Maja, Wojtkiewicz, Joanna

    “…Rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), ankylosing spondylitis (AS), and psoriatic arthritis (PsA) make up a group of chronic…”
    Get full text
    Journal Article
  5. 5

    Role of Distinct Macrophage Populations in the Development of Heart Failure in Macrophage Activation Syndrome by Kuna, Jakub, Żuber, Zbigniew, Chmielewski, Grzegorz, Gromadziński, Leszek, Krajewska-Włodarczyk, Magdalena

    “…Macrophage activation syndrome (MAS) is one of the few entities in rheumatology with the potential to quickly cause multiple organ failure and loss of life,…”
    Get full text
    Journal Article
  6. 6

    Physician Adherence to Treat-to-Target and Practice Guidelines in Rheumatoid Arthritis by Batko, Bogdan, Batko, Krzysztof, Krzanowski, Marcin, Żuber, Zbigniew

    Published in Journal of clinical medicine (08-09-2019)
    “…Principles of treat-to-target (T2T) have been widely adopted in both multinational and regional guidelines for rheumatoid arthritis (RA). Several questionnaire…”
    Get full text
    Journal Article
  7. 7

    Access to biologics and Janus kinase inhibitors for treatment of rheumatic diseases in the biosimilars era in Poland: a nation-level study by Stajszczyk, Marcin, Kwiatkowska, Brygida, Żuber, Zbigniew M, Batko, Bogdan

    Published in Polskie archiwum medycyny wewne̦trznej (26-04-2024)
    “…By reducing treatment costs, biosimilars provide an opportunity to improve accessibility to highly effective drugs. This study aimed to evaluate access to…”
    Get more information
    Journal Article
  8. 8

    Coexisting Sacroiliac Arthritis and Chronic Nonbacterial Osteomyelitis in an Adolescent with Ehlers-Danlos Syndrome: A Case Report and Treatment Success by Ożga, Joanna, Mężyk, Elżbieta, Kmiecik, Wojciech, Wojciechowski, Wadim, Żuber, Zbigniew

    Published in The American journal of case reports (22-09-2024)
    “…BACKGROUND Chronic nonbacterial osteomyelitis (CNO) is a multifocal autoinflammatory bone disease mainly affecting children and adolescents. Sacroiliitis is an…”
    Get full text
    Journal Article
  9. 9

    Magnetic resonance imaging of the musculoskeletal system in the diagnosis of rheumatic diseases in the pediatric population by Ożga, Joanna, Mężyk, Elżbieta, Kmiecik, Wojciech, Wojciechowski, Wadim, Żuber, Zbigniew

    Published in Reumatologia (01-01-2024)
    “…Magnetic resonance imaging (MRI) of the musculoskeletal system is an examination increasingly performed for suspected juvenile idiopathic arthritis, chronic…”
    Get full text
    Journal Article
  10. 10

    Vaccinations in Selected Immune-Related Diseases Treated with Biological Drugs and JAK Inhibitors-Literature Review and Statement of Experts from Polish Dermatological Society by Narbutt, Joanna, Żuber, Zbigniew, Lesiak, Aleksandra, Bień, Natalia, Szepietowski, Jacek C

    Published in Vaccines (Basel) (01-01-2024)
    “…The growing use of biological drugs in immune-mediated chronic diseases has undoubtedly revolutionized their treatment. Yet, the topic of vaccinations in this…”
    Get full text
    Journal Article
  11. 11

    Diagnosis and Management of Mucopolysaccharidosis Type II (Hunter Syndrome) in Poland by Żuber, Zbigniew, Kieć-Wilk, Beata, Kałużny, Łukasz, Wierzba, Jolanta, Tylki-Szymańska, Anna

    Published in Biomedicines (01-06-2023)
    “…Mucopolysaccharidosis type II (MPS II; also known as Hunter syndrome) is a rare, inherited lysosomal storage disease. The disease is caused by deficiency of…”
    Get full text
    Journal Article
  12. 12

    Antibodies Recognizing Yersinia enterocolitica Lipopolysaccharides of Various Chemotypes in Synovial Fluids From Patients With Juvenile Idiopathic Arthritis by Kasperkiewicz, Katarzyna, Świerzko, Anna S., Michalski, Mateusz, Eppa, Łukasz, Skurnik, Mikael, Żuber, Zbigniew, Cedzyński, Maciej

    Published in Journal of immunology research (2022)
    “…Yersinia enterocolitica O:3 (YeO3) is considered to be associated with reactive arthritis (ReA), and its lipopolysaccharide (LPS) has been detected in synovial…”
    Get full text
    Journal Article
  13. 13

    Deep dive into achieving the therapeutic target: results from a prospective, 6‑month, observational study nested in routine rheumatoid arthritis care by Batko, Bogdan, Jeka, Sławomir, Wiland, Piotr, Brzosko, Marek, Samborski, Włodzimierz, Stajszczyk, Marcin, Chudek, Jerzy, Żuber, Zbigniew

    Published in Polskie archiwum medycyny wewne̦trznej (26-09-2022)
    “…Achieving remission or lowdisease activity (LDA) is an integral principle of treat‑to‑target (T2T) strategy in rheumatoid arthritis (RA). Prior studies have…”
    Get more information
    Journal Article
  14. 14

    Ultrasound Evaluation of the Effectiveness of the Use of Acitretin in the Treatment of Nail Psoriasis by Krajewska-Włodarczyk, Magdalena, Żuber, Zbigniew, Owczarczyk-Saczonek, Agnieszka

    Published in Journal of clinical medicine (14-05-2021)
    “…The study aimed to evaluate the effect of retinoid treatment on the morphological changes in the nail apparatus in patients with nail psoriasis. Material and…”
    Get full text
    Journal Article
  15. 15

    COVID-19 prophylaxis, diagnostics, and treatment in patients with rheumatic diseases. The Polish experts panel opinion by Kwiatkowska, Brygida, Krajewska-Włodarczyk, Magdalena, Batko, Bogdan, Maślińska, Maria, Stajszczyk, Marcin, Świerkot, Jerzy, Wiland, Piotr, Żuber, Zbigniew, Tomasiewicz, Krzysztof

    Published in Reumatologia (01-01-2024)
    “…As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolves, infection management in vulnerable populations requires formalized guidance. Although…”
    Get full text
    Journal Article
  16. 16

    Real-World Data from a Multi-Center Study: Insights to Psoriatic Arthritis Care by Batko, Bogdan, Kucharz, Eugeniusz, Stajszczyk, Marcin, Brzosko, Marek, Samborski, Włodzimierz, Żuber, Zbigniew

    Published in Journal of clinical medicine (11-09-2021)
    “…Introduction: Real-world data indicate disparities in biologic access across Europe. Objectives: To describe the national structure of PsA care in Poland, with…”
    Get full text
    Journal Article
  17. 17

    The effect of recombinant human iduronate-2-sulfatase (Idursulfase) on growth in young patients with mucopolysaccharidosis type II by Żuber, Zbigniew, Różdżyńska-Świątkowska, Agnieszka, Jurecka, Agnieszka, Tylki-Szymańska, Anna

    Published in PloS one (13-01-2014)
    “…Mucopolysaccharidosis type II (MPS II; Hunter syndrome) is an X-linked, recessive, lysosomal storage disorder caused by deficiency of iduronate-2-sulfatase…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Newly developed cardiovascular risk factors in rheumatoid arthritis patients initiating biologic treatment by Zaręba, Wojciech, Krawiec, Piotr, Banaszkiewicz, Małgorzata, Batko, Krzysztof, Gołąb, Aleksandra, Plicner, Dariusz, Żuber, Zbigniew, Batko, Bogdan

    Published in Reumatologia (01-01-2023)
    “…Rheumatoid arthritis (RA) is a risk factor (RF) for cardiovascular (CV) disease, a leading cause of mortality in RA patients. Consecutive records of RA…”
    Get full text
    Journal Article
  20. 20